
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/zoUGgY0ZH44
Canadian bioengineers have developed the technology for diagnosing and analyzing cancers in the brain using a 3D printed ultrasensitive nanosensor capable of detecting tumor-specific proteins in at little as 5 ul of blood using surface-enhanced Raman scattering methodology.
This liquid biopsy system can detect a primary or secondary tumor with nearly 100% accuracy and the intracranial location of that tumor with 96% accuracy.
https://pubs.acs.org/doi/10.1021/acsnano.2c04187?goto=supporting-info
#braincancer #liquidbiopsy #nanosensor #sers
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/zoUGgY0ZH44
Canadian bioengineers have developed the technology for diagnosing and analyzing cancers in the brain using a 3D printed ultrasensitive nanosensor capable of detecting tumor-specific proteins in at little as 5 ul of blood using surface-enhanced Raman scattering methodology.
This liquid biopsy system can detect a primary or secondary tumor with nearly 100% accuracy and the intracranial location of that tumor with 96% accuracy.
https://pubs.acs.org/doi/10.1021/acsnano.2c04187?goto=supporting-info
#braincancer #liquidbiopsy #nanosensor #sers